Sphingolipid activator protein (SAP) deficiency, previously described in two sibs and shown to be caused by the absence of the common saposin precursor (prosaposin), was further characterized by biochemical lipid and enzyme studies and by ultrastructural analysis. The 20-week-old fetal sib had increased concentrations of neutral glycolipids, including mono-, di-, tri- and tetrahexosylceramide, in liver, kidney and cultured skin fibroblasts compared with the controls. Glucosylceramide and lactosylceramide were particularly elevated. The kidney of the affected fetus showed additional increases in the concentration of sulphatide, galactosylceramide and digalactosylceramide. Free ceramide was stored in the liver and kidney, and GM3 and GM2 gangliosides were elevated in the liver, but not the brain, of the fetus. Phospholipids, however, were normal in the affected fetus. In the liver biopsy of the propositus, who later died at 16 weeks of age, only a few lipids could be studied. Glucosylceramide, dihexosylceramide and ceramide were elevated in agreement with our previous study. Enzyme studies were undertaken using detergent-free liposomal substrate preparations and fibroblast extracts. The sibs' beta-glucocerebrosidase and beta-galactocerebrosidase activities were clearly reduced, but their sphingomyelinase activities were normal. The normal activity of the latter enzyme and the almost normal tissue concentration of sphingomyelin in prosaposin deficiency suggest that the prosaposin-derived SAPs are not required for sphingomyelinase activity in vivo. In keeping with the biochemical findings, skin biopsies from the sibs showed massive lysosomal storage with a vesicular and membranous ultrastructure. The function of SAPs in sphingolipid degradation and the role of SAPs for enzyme activity in vitro are discussed. In addition, the similarity in neutral glycolipid accumulations in Niemann-Pick disease type C and in prosaposin deficiency are noted. The phenotype of the prosaposin deficient sibs resembled acute neuronopathic (type 2) Gaucher disease more than Farber disease in several aspects, but their genotype was unique.

Hlava Institute of Pathology 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Clin Chim Acta. 1985 Mar 15;146(2-3):147-56 PubMed

Dev Neurosci. 1991;13(4-5):307-14 PubMed

J Biol Chem. 1992 Feb 15;267(5):3312-5 PubMed

Biochim Biophys Acta. 1986 Nov 14;879(2):215-20 PubMed

J Chromatogr. 1990 Nov 30;533:297-9 PubMed

J Biol Chem. 1991 Aug 15;266(23):15021-7 PubMed

Klin Wochenschr. 1989 Oct 2;67(19):999-1003 PubMed

Biol Chem Hoppe Seyler. 1988 May;369(5):317-28 PubMed

Lipids. 1970 May;5(5):494-6 PubMed

J Biol Chem. 1990 Feb 5;265(4):1933-7 PubMed

Proc Natl Acad Sci U S A. 1989 May;86(9):3389-93 PubMed

Proc Natl Acad Sci U S A. 1983 Mar;80(5):1313-7 PubMed

Arch Biochem Biophys. 1987 Dec;259(2):627-38 PubMed

Anal Biochem. 1985 Apr;146(1):220-31 PubMed

Virchows Arch A Pathol Anat Histopathol. 1984;402(3):307-17 PubMed

J Chromatogr. 1973 Nov 7;86(1):200-4 PubMed

Science. 1988 Aug 26;241(4869):1098-101 PubMed

Biol Chem Hoppe Seyler. 1986 Sep;367(9):879-90 PubMed

Biochim Biophys Acta. 1984 Apr 18;793(2):141-8 PubMed

Am J Hum Genet. 1981 Nov;33(6):900-6 PubMed

Biol Chem Hoppe Seyler. 1985 Mar;366(3):245-56 PubMed

Proc Natl Acad Sci U S A. 1978 Aug;75(8):3979-83 PubMed

Eur J Pediatr. 1989 Oct;149(1):31-9 PubMed

Methods Enzymol. 1987;138:792-815 PubMed

Hum Genet. 1992 Jul;89(5):513-8 PubMed

J Biol Chem. 1985 Feb 10;260(3):1867-71 PubMed

Biochim Biophys Acta. 1982 Sep 14;712(3):639-49 PubMed

FASEB J. 1991 Mar 1;5(3):301-8 PubMed

Eur J Cell Biol. 1990 Feb;51(1):157-64 PubMed

Pediatr Neurol. 1990 May-Jun;6(3):177-83 PubMed

J Biol Chem. 1957 May;226(1):497-509 PubMed

J Lipid Res. 1980 Jan;21(1):53-64 PubMed

Biochem Biophys Res Commun. 1988 Oct 14;156(1):403-10 PubMed

Biochem J. 1992 Jul 15;285 ( Pt 2):481-8 PubMed

Enzyme. 1987;38(1-4):262-6 PubMed

J Neurochem. 1956 May;1(1):42-53 PubMed

FEBS Lett. 1991 Jun 17;284(1):57-9 PubMed

Science. 1973 Jul 27;181(4097):352-4 PubMed

Biochem J. 1988 Aug 15;254(1):77-84 PubMed

Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations

Neurolysosomal pathology in human prosaposin deficiency suggests essential neurotrophic function of prosaposin

Lactosylceramide in lysosomal storage disorders: a comparative immunohistochemical and biochemical study

Leptomeningeal lipid storage patterns in Fabry disease